Evidence map›Paper›PMID 37811897›Full record

ArticleNucleic acids research2024

SORC: an integrated spatial omics resource in cancer.

Weiwei Zhou, Minghai Su, Tiantongfei Jiang, Qingyi Yang, Qisen Sun, Kang Xu, Jingyi Shi, Changbo Yang, Na Ding, Yongsheng Li and 1 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Cancer therapy resistance from a spatial-omics perspective.Clinical and translational medicine · 2025
    Review
  14. Article
  15. HISSTA: a human in situ single-cell transcriptome atlas.Bioinformatics (Oxford, England) · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Weiwei ZhouCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, Heilongjiang Province, China.
Minghai SuCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, Heilongjiang Province, China.ORCID 0000-0001-5135-3103
Tiantongfei JiangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, Heilongjiang Province, China.
Qingyi YangSchool of Interdisciplinary Medicine and Engineering, Harbin Medical University, Harbin 150081, Heilongjiang Province, China.
Qisen SunCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, Heilongjiang Province, China.
Kang XuCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, Heilongjiang Province, China.
Jingyi ShiCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, Heilongjiang Province, China.
Changbo YangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, Heilongjiang Province, China.
Na DingCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, Heilongjiang Province, China.
Yongsheng LiSchool of Interdisciplinary Medicine and Engineering, Harbin Medical University, Harbin 150081, Heilongjiang Province, China.ORCID 0000-0003-1914-0727
Juan XuCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, Heilongjiang Province, China.ORCID 0000-0002-3709-4165

Funding

National Natural Science Foundation of China 32322020Natural Science Foundation of Heilongjiang Province ZD2023C007
6 · The paper itself

Abstract

The interactions between tumor cells and the microenvironment play pivotal roles in the initiation, progression and metastasis of cancer. The advent of spatial transcriptomics data offers an opportunity to unravel the intricate dynamics of cellular states and cell-cell interactions in cancer. Herein, we have developed an integrated spatial omics resource in cancer (SORC, http://bio-bigdata.hrbmu.edu.cn/SORC), which interactively visualizes and analyzes the spatial transcriptomics data in cancer. We manually curated currently available spatial transcriptomics datasets for 17 types of cancer, comprising 722 899 spots across 269 slices. Furthermore, we matched reference single-cell RNA sequencing data in the majority of spatial transcriptomics datasets, involving 334 379 cells and 46 distinct cell types. SORC offers five major analytical modules that address the primary requirements of spatial transcriptomics analysis, including slice annotation, identification of spatially variable genes, co-occurrence of immune cells and tumor cells, functional analysis and cell-cell communications. All these spatial transcriptomics data and in-depth analyses have been integrated into easy-to-browse and explore pages, visualized through intuitive tables and various image formats. In summary, SORC serves as a valuable resource for providing an unprecedented spatially resolved cellular map of cancer and identifying specific genes and functional pathways to enhance our understanding of the tumor microenvironment.

Indexed as

Databases, GeneticNeoplasmsGene Expression ProfilingHumansTranscriptomeTumor Microenvironment

Identifiers

PMID37811897
PMCPMC10768140

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.